[22, 30] In this Gefitinib study we have demonstrated that women requesting EC from a pharmacy meet the NSTIS criteria of being a high-risk sub-population and should therefore be given a chlamydia test. An Australian study conducted in 2007 found that almost 80% of 25 community pharmacists and 50 young females surveyed would support a pharmacy-based chlamydia screening programme.[32] Yet there is no mechanism in place for pharmacists to request a chlamydia test under the current health system structure in Australia. Further research needs to be conducted to develop sustainable approaches that would allow pharmacists to offer a chlamydia test this cohort of

high-risk women. The infrastructure by which pharmacists would request a chlamydia pathology test, chlamydia test results would be distributed and any chlamydia-positive consumers would access treatment need to be determined. Almost all the women requesting EC from a community pharmacy were between 16 and 29 years of age and had inconsistent barrier contraception, placing them at high risk of chlamydia. While pharmacy provides a timely and accessible route for obtaining EC, it can prevent women from getting a chlamydia test and an STI risk assessment, thus unwittingly http://www.selleckchem.com/products/torin-1.html putting them at higher risk of carrying an STI undetected. This gap in sexual health

provision exposes an urgent need to re-orientate current sexual health services so that all EC consumers – including those obtaining EC from pharmacies Resveratrol – have the opportunity to be tested for chlamydia. In England, community pharmacies have successfully implemented chlamydia screening, providing a convenient and easily accessible venue to young

people. We are in a unique position in Australia to be able to learn from overseas experience to determine the most effective approach to test pharmacy-based EC consumers for chlamydia. The Author(s) declare(s) that they have no conflicts of interest to disclose. Part of the study that investigated risk factors in rural, regional and remote Western Australia was funded by the Small Project Funding Scheme as a component of Rural Pharmacy Workforce Program, which was part of the Fourth Pharmacy Agreement, and managed by the Pharmacy Guild of Australia. We thank Miss Sanjani Wijesinghe for here contribution is developing the survey and data collection in Perth metropolitan region. Sajni Gudka, Kim Watkins and Atefeh Eshghabadi conceptualized, designed and conducted the research under the supervision of Rhonda Clifford and Alan Everett. Sajni Gudka and Aline Bourdin analysed and interpreted the data. Sajni Gudka wrote the manuscript under the supervision of Rhonda Clifford and Alan Everett. All authors had complete access to the study data. They reviewed and commented on drafts of the manuscript written by Sajni Gudka.